Barclays PLC Has $1.36 Million Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Barclays PLC raised its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 9,643.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 31,471 shares of the company’s stock after buying an additional 31,148 shares during the period. Barclays PLC owned about 0.11% of Establishment Labs worth $1,362,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in ESTA. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Establishment Labs by 89.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 41,351 shares of the company’s stock worth $1,789,000 after purchasing an additional 19,531 shares during the last quarter. Divisadero Street Capital Management LP purchased a new position in Establishment Labs during the second quarter worth about $5,829,000. Sei Investments Co. grew its position in Establishment Labs by 634.5% in the 2nd quarter. Sei Investments Co. now owns 40,576 shares of the company’s stock worth $1,844,000 after purchasing an additional 35,052 shares in the last quarter. Sofinnova Investments Inc. increased its stake in Establishment Labs by 204.1% in the 2nd quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company’s stock valued at $19,505,000 after buying an additional 288,082 shares during the last quarter. Finally, Lighthouse Investment Partners LLC boosted its stake in shares of Establishment Labs by 191.2% in the 2nd quarter. Lighthouse Investment Partners LLC now owns 42,702 shares of the company’s stock worth $1,940,000 after buying an additional 28,038 shares during the last quarter. 72.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have recently commented on ESTA. BTIG Research lifted their target price on Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Stephens raised shares of Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. Finally, Citigroup lifted their price target on Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Establishment Labs currently has an average rating of “Buy” and an average target price of $60.60.

Establishment Labs Stock Performance

Establishment Labs stock opened at $45.79 on Monday. The firm’s 50 day simple moving average is $44.31 and its 200 day simple moving average is $43.75. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 1-year low of $31.20 and a 1-year high of $60.12. The firm has a market capitalization of $1.28 billion, a PE ratio of -17.75 and a beta of 1.15.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.